In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
The closing price of Centessa Pharmaceuticals plc ADR (NASDAQ: CNTA) was $16.59 for the day, up 1.04% from the previous closing price of $16.42. In other words, the price has increased by $1.04 from its previous closing price. On the day, 0.8 million shares were traded. CNTA stock price reached its highest trading level at $16.83 during the session, while it also had its lowest trading level at $15.51.
Ratios:
Our analysis of CNTA’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 21.52 and its Current Ratio is at 21.52. In the meantime, Its Debt-to-Equity ratio is 0.17 whereas as Long-Term Debt/Eq ratio is at 0.17.
On September 20, 2024, Morgan Stanley Upgraded its rating to Overweight which previously was Equal-Weight and also upped its target price recommendation from $11 to $26.
On September 19, 2024, B. Riley Securities started tracking the stock assigning a Buy rating and target price of $33.B. Riley Securities initiated its Buy rating on September 19, 2024, with a $33 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jan 27 ’25 when Weinhoff Gregory M sold 11,742 shares for $16.47 per share. The transaction valued at 193,429 led to the insider holds 159,782 shares of the business.
Weinhoff Gregory M bought 11,742 shares of CNTA for $193,429 on Jan 27 ’25. On Jan 21 ’25, another insider, SAHA SAURABH, who serves as the Chief Executive Officer of the company, sold 55,000 shares for $15.77 each. As a result, the insider received 867,430 and left with 429,398 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CNTA now has a Market Capitalization of 2187308544 and an Enterprise Value of 1485903232. For the stock, the TTM Price-to-Sale (P/S) ratio is 316.10 while its Price-to-Book (P/B) ratio in mrq is 4.38. Its current Enterprise Value per Revenue stands at 216.825 whereas that against EBITDA is -9.212.
Stock Price History:
The Beta on a monthly basis for CNTA is 1.53, which has changed by 1.004884 over the last 52 weeks, in comparison to a change of 0.25219524 over the same period for the S&P500. Over the past 52 weeks, CNTA has reached a high of $18.97, while it has fallen to a 52-week low of $7.38. The 50-Day Moving Average of the stock is -1.43%, while the 200-Day Moving Average is calculated to be 26.21%.
Shares Statistics:
CNTA traded an average of 582.89K shares per day over the past three months and 481320 shares per day over the past ten days. A total of 131.66M shares are outstanding, with a floating share count of 90.14M. Insiders hold about 31.53% of the company’s shares, while institutions hold 51.07% stake in the company. Shares short for CNTA as of 1736899200 were 3289465 with a Short Ratio of 5.64, compared to 1734048000 on 3633001. Therefore, it implies a Short% of Shares Outstanding of 3289465 and a Short% of Float of 3.06.
